https://www.epmmagazine.com/topics/catalent/index.rss en-gb © 2020 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved. Thu, 30 Jul 2020 08:20:00 -0000 Catalent will help Editas Medicine with the development of the company’s portfolio of cell and CRISPR medicines, the company has announced. https://www.epmmagazine.com/news/catalent-partners-with-gene/ https://www.epmmagazine.com/news/catalent-partners-with-gene/ Thu, 30 Jul 2020 08:20:00 -0000 CRISPR Drug delivery technology provider Catalent will invest €27 million in its facility in France to create a European centre of excellence for clinical biologics formulation development and drug product fill-finish services. https://www.epmmagazine.com/news/catalent-to-create-european-centre-of-excellence-through-%E2%82%AC27/ https://www.epmmagazine.com/news/catalent-to-create-european-centre-of-excellence-through-%E2%82%AC27/ Wed, 22 Jul 2020 10:21:37 -0000 Investment Advanced drug delivery technology provider Catalent will support the production of 100 million doses of biotech Moderna’s Covid-19 candidate vaccine as the result of a new collaboration. https://www.epmmagazine.com/news/catalent-to-support-production-of-moderna-s-covid-19-vaccine/ https://www.epmmagazine.com/news/catalent-to-support-production-of-moderna-s-covid-19-vaccine/ Tue, 30 Jun 2020 08:40:00 -0000 Medicine vials Drug delivery technology provider Catalent will acquire a clinical packaging facility in Japan, in a deal made with Teva-Takeda Pharmaceuticals. https://www.epmmagazine.com/news/catalent-to-acquire-japanese-facility-to-expand-global-clini/ https://www.epmmagazine.com/news/catalent-to-acquire-japanese-facility-to-expand-global-clini/ Thu, 21 May 2020 09:10:00 -0000 Catalent Facility Drug delivery technology provider Catalent will work alongside Johnson & Johnson to help deliver the pharma giant’s lead vaccine candidate for Covid-19. https://www.epmmagazine.com/news/catalent-to-help-johnson-johnson-manufacture-covid-19-vaccin/ https://www.epmmagazine.com/news/catalent-to-help-johnson-johnson-manufacture-covid-19-vaccin/ Thu, 30 Apr 2020 08:40:00 -0000 Handshake Drug delivery technology provider Catalent has completed a $14 million expansion to increase the biologics packaging capabilities and capacity at its Bloomington, Indiana facility. https://www.epmmagazine.com/news/catalent-increases-biologics-packaging-with-14m-expansion/ https://www.epmmagazine.com/news/catalent-increases-biologics-packaging-with-14m-expansion/ Mon, 27 Apr 2020 09:30:00 -0000 US expansion Contract drug manufacturer Catalent has launched a new direct-to-patient service for clinical trials, the company has announced. https://www.epmmagazine.com/news/catalent-launches-servie/ https://www.epmmagazine.com/news/catalent-launches-servie/ Wed, 15 Jan 2020 10:45:00 -0000 Catalent William Wei Lim Chin William Wei Lim Chin, technical specialist, Science and Technology at Catalent explains why spray drying is essential for overcoming solubility issues. https://www.epmmagazine.com/opinion/spray-drying/ https://www.epmmagazine.com/opinion/spray-drying/ Tue, 07 Jan 2020 09:45:00 -0000 Solubility European Pharmaceutical Manufacturer examines some of the biggest trends that have taken place throughout 2019. https://www.epmmagazine.com/opinion/the-state-of-pharma-in-2019/ https://www.epmmagazine.com/opinion/the-state-of-pharma-in-2019/ Fri, 13 Dec 2019 09:10:00 -0000 Pharma Trends The winners of this year's 2019 CPhI Awards have been announced with companies including Cambrex, Catalent and Merck Healthcare taking home accolades. https://www.epmmagazine.com/news/2019-cphi-awards-winners-announced/ https://www.epmmagazine.com/news/2019-cphi-awards-winners-announced/ Wed, 06 Nov 2019 08:45:00 -0000 Awards Contract drug manufacturer Catalent has launched a new integrated suite of equipment to help address challenges facing biologic development. https://www.epmmagazine.com/news/catalent-launches-integrated-suite-for-biologics/ https://www.epmmagazine.com/news/catalent-launches-integrated-suite-for-biologics/ Sun, 09 Jun 2019 23:00:00 -0000 Biologics Contract drug manufacturer Catalent has completed its $1.2 billion acquisition of gene therapy manufacturer Paragon Bioservices, the company has announced. https://www.epmmagazine.com/news/catalent-completes-acquisition-of-gene-therapy/ https://www.epmmagazine.com/news/catalent-completes-acquisition-of-gene-therapy/ Tue, 21 May 2019 08:30:00 -0000 Gene therapies Contract drug manufacturer Catalent has announced it is to acquire leading gene therapy company Paragon Bioservices for $1.2 billion. https://www.epmmagazine.com/news/catalent-to-acquire-pharmatek-move-adds-expanded-drug-develo_1/ https://www.epmmagazine.com/news/catalent-to-acquire-pharmatek-move-adds-expanded-drug-develo_1/ Tue, 16 Apr 2019 09:10:00 -0000 DNA Catalent, provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has completed its tender offer for all outstanding shares of Juniper Pharmaceuticals. https://www.epmmagazine.com/news/catalent-completes-tender-offer-for-jupiter/ https://www.epmmagazine.com/news/catalent-completes-tender-offer-for-jupiter/ Tue, 21 Aug 2018 12:54:29 -0000 stocks and shares Catalent, global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has signed an agreement for the acquisition of Juniper Pharmaceuticals. https://www.epmmagazine.com/news/catalent-signs-agreement-for-acquisition-of-juniper-pharma/ https://www.epmmagazine.com/news/catalent-signs-agreement-for-acquisition-of-juniper-pharma/ Wed, 04 Jul 2018 10:42:31 -0000 Partnership Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. https://www.epmmagazine.com/news/the-top-five-tweets-from-brexit-to-effects-of-ais/ https://www.epmmagazine.com/news/the-top-five-tweets-from-brexit-to-effects-of-ais/ Fri, 22 Jun 2018 14:00:00 -0000 Top five Ralph Gosden Do you encounter difficulties when swallowing tablets? Head of product development at Catalent Pharma Solutions, Ralph Gosden, reveals why the Zydis platform is still a game changer, and what is on the cards for the near future. https://www.epmmagazine.com/opinion/the-soluble-option/ https://www.epmmagazine.com/opinion/the-soluble-option/ Fri, 22 Dec 2017 09:00:00 -0000 The soluble option Global provider of advanced delivery technologies and development solutions, Catalent, and clinical-stage biotechnology company, Vaccinex, have signed an agreement for the development of an antibody drug conjugate (ADC) to be used against cancer https://www.epmmagazine.com/news/catalent-and-vaccinex-to-collaborate-on-development-of-adc/ https://www.epmmagazine.com/news/catalent-and-vaccinex-to-collaborate-on-development-of-adc/ Thu, 07 Dec 2017 12:05:09 -0000 Collaboration As we reach the end of CPhI Worldwide, we have some more revelations and innovations that keep coming from the vast show floor here in Frankfurt Messe, enjoy and until next year tschüß! https://www.epmmagazine.com/news/floor-fillers-day-3-%E2%80%94-the-latest-from-cphi-ww%E2%80%99s-show-floor/ https://www.epmmagazine.com/news/floor-fillers-day-3-%E2%80%94-the-latest-from-cphi-ww%E2%80%99s-show-floor/ Thu, 26 Oct 2017 06:09:09 -0000 Frankfurt old town Brian Fahie Michael Merges Here, Michael Merges, Catalent Biologics, and Brian Fahie, Biogen, discuss the growing need for partners who can provide niche technologies to accelerate development projects. https://www.epmmagazine.com/opinion/the-perfect-partnership-%E2%80%94-looking-at-the-growing-need-for-st/ https://www.epmmagazine.com/opinion/the-perfect-partnership-%E2%80%94-looking-at-the-growing-need-for-st/ Fri, 22 Sep 2017 12:49:06 -0000 The perfect partnership Global provider of advanced delivery technologies and development solutions for drugs, Catalent, has reached an agreement to purchase Cook Pharmica, an integrated provider of drug substance and drug product manufacturing and related services. https://www.epmmagazine.com/news/catalent-to-acquire-biologics-focused-cdmo/ https://www.epmmagazine.com/news/catalent-to-acquire-biologics-focused-cdmo/ Wed, 20 Sep 2017 10:29:29 -0000 Acquisition June Lin As Catalent further expands its softgel drug delivery capabilities with its acquisition of Accucaps, we speak with June Lin, global marketing director consumer health softgel, about the benefits these expanded capabilities will offer. https://www.epmmagazine.com/opinion/a-soft-spot-catalent-discusses-the-benefits-of-its-further-e/ https://www.epmmagazine.com/opinion/a-soft-spot-catalent-discusses-the-benefits-of-its-further-e/ Mon, 26 Jun 2017 10:58:08 -0000 A soft spot Lu Rahman Catalent Pharma Solutions has revealed its agenda for the upcoming CPhI North America Conference and Exhibition https://www.epmmagazine.com/news/catalent-outlines-cphi-north-america-offering/ https://www.epmmagazine.com/news/catalent-outlines-cphi-north-america-offering/ Fri, 12 May 2017 07:12:20 -0000 philadelphia.gif Global supply partner for drugs, biologics and consumer health products, Catalent, has announced that it has completed the acquisition of pharmaceutical softgels developer and manufacturer, Accucaps. https://www.epmmagazine.com/news/catalent-acquires-accucaps/ https://www.epmmagazine.com/news/catalent-acquires-accucaps/ Thu, 16 Feb 2017 15:55:00 -0000 Softgel Chris Halling, director, global communications & marketing at Catalent writes about how drug design affects patient adherence. https://www.epmmagazine.com/news/winning-design-designing-drugs-for-better-patient-adherence/ https://www.epmmagazine.com/news/winning-design-designing-drugs-for-better-patient-adherence/ Mon, 23 Jan 2017 16:20:00 -0000 Pills Provider of advanced delivery technologies and development solutions for drugs, Catalent Pharma Solutions has announced it will develop softgel technology for pharma company, Jupiter Orphan Therapeutics’ (JOT) formulation of resveratrol, JOTORL. https://www.epmmagazine.com/news/catalent-to-develop-softgel-capsules-for-jot%E2%80%99s-leading-orpha/ https://www.epmmagazine.com/news/catalent-to-develop-softgel-capsules-for-jot%E2%80%99s-leading-orpha/ Wed, 11 Jan 2017 10:50:00 -0000 Softgel Catalent Pharma Solutions, provider of advanced delivery technologies and development solutions for drugs has announced a collaboration with Path, a nonprofit organisation to advance a project funded by its Malaria Vaccine Initiative. https://www.epmmagazine.com/news/catalent-biologics-partners-with-path-malaria-vaccine-initia/ https://www.epmmagazine.com/news/catalent-biologics-partners-with-path-malaria-vaccine-initia/ Mon, 19 Dec 2016 10:25:00 -0000 Malaria Dave Gray Global CDMO Catalent has announced its enrollment in the Pharmaceutical Supply Chain Initiative (PSCI) https://www.epmmagazine.com/news/pharmaceutical-supply-chain-initiative-catalent-cdmo/ https://www.epmmagazine.com/news/pharmaceutical-supply-chain-initiative-catalent-cdmo/ Fri, 09 Dec 2016 11:26:00 -0000 supplychain.jpg Provider of advanced delivery technologies, Catalent Pharma Solutions, has announced it will provide fill-finish production services for the commercial supply of SB4, a biosimilar referencing Enbrel, which is used to treat five chronic diseases. https://www.epmmagazine.com/news/catalent-to-provide-fill-and-finish-services-for-samsung-bio/ https://www.epmmagazine.com/news/catalent-to-provide-fill-and-finish-services-for-samsung-bio/ Tue, 25 Oct 2016 07:50:00 -0000 Pre-Fill Syringes Acquisition of west coast development and clinical manufacturing specialist will add formulation development capabilities and expands bioavailability enhancement solutions. https://www.epmmagazine.com/news/catalent-to-acquire-pharmatek-move-adds-expanded-drug-develo/ https://www.epmmagazine.com/news/catalent-to-acquire-pharmatek-move-adds-expanded-drug-develo/ Tue, 13 Sep 2016 14:30:00 -0000 Catalent